Watson Pharmaceuticals Inc. / Schein Pharmaceutical Inc.
2000 · Acquisition/Merger · $674M · Complete
Announcement Sentiment
83
Strongly positive
Watson Pharmaceuticals announced a two-step acquisition of Schein Pharmaceutical valued at ~$674M (cash tender at $19.50 plus stock-merger second step). Bayer Corp. and Schein family controlled 74% and tendered. Created a $1.2B generics business. Closed Sep 2000.